CN114381456B - Artificially synthesized nano silver synthetic protein gene, expressed protein and application thereof - Google Patents
Artificially synthesized nano silver synthetic protein gene, expressed protein and application thereof Download PDFInfo
- Publication number
- CN114381456B CN114381456B CN202111665678.8A CN202111665678A CN114381456B CN 114381456 B CN114381456 B CN 114381456B CN 202111665678 A CN202111665678 A CN 202111665678A CN 114381456 B CN114381456 B CN 114381456B
- Authority
- CN
- China
- Prior art keywords
- protein
- nano silver
- gene
- silver
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 72
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 title claims abstract description 58
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 50
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 12
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 10
- 239000013598 vector Substances 0.000 claims description 12
- 230000002194 synthesizing effect Effects 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 6
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 6
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 2
- 239000000758 substrate Substances 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 10
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 6
- 102000008857 Ferritin Human genes 0.000 abstract description 3
- 108050000784 Ferritin Proteins 0.000 abstract description 3
- 238000008416 Ferritin Methods 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 35
- 150000001413 amino acids Chemical group 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 239000002245 particle Substances 0.000 description 10
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000012634 fragment Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 102000005298 Iron-Sulfur Proteins Human genes 0.000 description 4
- 108010081409 Iron-Sulfur Proteins Proteins 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 229910052709 silver Inorganic materials 0.000 description 4
- 239000004332 silver Substances 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- 239000006137 Luria-Bertani broth Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000012460 protein solution Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 241001360526 Escherichia coli ATCC 25922 Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 2
- 240000000220 Panda oleosa Species 0.000 description 2
- 235000016496 Panda oleosa Nutrition 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 108010049041 glutamylalanine Proteins 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000000053 physical method Methods 0.000 description 2
- -1 silver ions Chemical class 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- GSHKMNKPMLXSQW-KBIXCLLPSA-N Ala-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C)N GSHKMNKPMLXSQW-KBIXCLLPSA-N 0.000 description 1
- CCDFBRZVTDDJNM-GUBZILKMSA-N Ala-Leu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CCDFBRZVTDDJNM-GUBZILKMSA-N 0.000 description 1
- KWKQGHSSNHPGOW-BQBZGAKWSA-N Arg-Ala-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)NCC(O)=O KWKQGHSSNHPGOW-BQBZGAKWSA-N 0.000 description 1
- NXDXECQFKHXHAM-HJGDQZAQSA-N Arg-Glu-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NXDXECQFKHXHAM-HJGDQZAQSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- KXEGPPNPXOKKHK-ZLUOBGJFSA-N Asn-Asp-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O KXEGPPNPXOKKHK-ZLUOBGJFSA-N 0.000 description 1
- ZLGKHJHFYSRUBH-FXQIFTODSA-N Asp-Arg-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLGKHJHFYSRUBH-FXQIFTODSA-N 0.000 description 1
- VAWNQIGQPUOPQW-ACZMJKKPSA-N Asp-Glu-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O VAWNQIGQPUOPQW-ACZMJKKPSA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241001508786 Citeromyces matritensis Species 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- NPTGGVQJYRSMCM-GLLZPBPUSA-N Gln-Gln-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NPTGGVQJYRSMCM-GLLZPBPUSA-N 0.000 description 1
- UFNSPPFJOHNXRE-AUTRQRHGSA-N Gln-Gln-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O UFNSPPFJOHNXRE-AUTRQRHGSA-N 0.000 description 1
- XJKAKYXMFHUIHT-AUTRQRHGSA-N Gln-Glu-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)N XJKAKYXMFHUIHT-AUTRQRHGSA-N 0.000 description 1
- DRNMNLKUUKKPIA-HTUGSXCWSA-N Gln-Phe-Thr Chemical compound C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCC(N)=O)C(O)=O DRNMNLKUUKKPIA-HTUGSXCWSA-N 0.000 description 1
- IESFZVCAVACGPH-PEFMBERDSA-N Glu-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCC(O)=O IESFZVCAVACGPH-PEFMBERDSA-N 0.000 description 1
- SOEPMWQCTJITPZ-SRVKXCTJSA-N Glu-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N SOEPMWQCTJITPZ-SRVKXCTJSA-N 0.000 description 1
- UZWUBBRJWFTHTD-LAEOZQHASA-N Glu-Val-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCC(O)=O UZWUBBRJWFTHTD-LAEOZQHASA-N 0.000 description 1
- NSTUFLGQJCOCDL-UWVGGRQHSA-N Gly-Leu-Arg Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NSTUFLGQJCOCDL-UWVGGRQHSA-N 0.000 description 1
- UUYBFNKHOCJCHT-VHSXEESVSA-N Gly-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN UUYBFNKHOCJCHT-VHSXEESVSA-N 0.000 description 1
- IBYOLNARKHMLBG-WHOFXGATSA-N Gly-Phe-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 IBYOLNARKHMLBG-WHOFXGATSA-N 0.000 description 1
- BDFCIKANUNMFGB-PMVVWTBXSA-N His-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CN=CN1 BDFCIKANUNMFGB-PMVVWTBXSA-N 0.000 description 1
- CKONPJHGMIDMJP-IHRRRGAJSA-N His-Val-His Chemical compound C([C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 CKONPJHGMIDMJP-IHRRRGAJSA-N 0.000 description 1
- AZEYWPUCOYXFOE-CYDGBPFRSA-N Ile-Arg-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C(C)C)C(=O)O)N AZEYWPUCOYXFOE-CYDGBPFRSA-N 0.000 description 1
- SCHZQZPYHBWYEQ-PEFMBERDSA-N Ile-Asn-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N SCHZQZPYHBWYEQ-PEFMBERDSA-N 0.000 description 1
- HVWXAQVMRBKKFE-UGYAYLCHSA-N Ile-Asp-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N HVWXAQVMRBKKFE-UGYAYLCHSA-N 0.000 description 1
- RGSOCXHDOPQREB-ZPFDUUQYSA-N Ile-Asp-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N RGSOCXHDOPQREB-ZPFDUUQYSA-N 0.000 description 1
- QRTVJGKXFSYJGW-KBIXCLLPSA-N Ile-Glu-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N QRTVJGKXFSYJGW-KBIXCLLPSA-N 0.000 description 1
- UWLHDGMRWXHFFY-HPCHECBXSA-N Ile-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@@H]1C(=O)O)N UWLHDGMRWXHFFY-HPCHECBXSA-N 0.000 description 1
- CKRFDMPBSWYOBT-PPCPHDFISA-N Ile-Lys-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N CKRFDMPBSWYOBT-PPCPHDFISA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- DLFAACQHIRSQGG-CIUDSAMLSA-N Leu-Asp-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O DLFAACQHIRSQGG-CIUDSAMLSA-N 0.000 description 1
- FMEICTQWUKNAGC-YUMQZZPRSA-N Leu-Gly-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O FMEICTQWUKNAGC-YUMQZZPRSA-N 0.000 description 1
- SYRTUBLKWNDSDK-DKIMLUQUSA-N Leu-Phe-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SYRTUBLKWNDSDK-DKIMLUQUSA-N 0.000 description 1
- PPGBXYKMUMHFBF-KATARQTJSA-N Leu-Ser-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PPGBXYKMUMHFBF-KATARQTJSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- VEGLGAOVLFODGC-GUBZILKMSA-N Lys-Glu-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O VEGLGAOVLFODGC-GUBZILKMSA-N 0.000 description 1
- GQZMPWBZQALKJO-UWVGGRQHSA-N Lys-Gly-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O GQZMPWBZQALKJO-UWVGGRQHSA-N 0.000 description 1
- WVJNGSFKBKOKRV-AJNGGQMLSA-N Lys-Leu-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WVJNGSFKBKOKRV-AJNGGQMLSA-N 0.000 description 1
- ONGCSGVHCSAATF-CIUDSAMLSA-N Met-Ala-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O ONGCSGVHCSAATF-CIUDSAMLSA-N 0.000 description 1
- OLWAOWXIADGIJG-AVGNSLFASA-N Met-Arg-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(O)=O OLWAOWXIADGIJG-AVGNSLFASA-N 0.000 description 1
- QGRJTULYDZUBAY-ZPFDUUQYSA-N Met-Ile-Glu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O QGRJTULYDZUBAY-ZPFDUUQYSA-N 0.000 description 1
- HOZNVKDCKZPRER-XUXIUFHCSA-N Met-Lys-Ile Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HOZNVKDCKZPRER-XUXIUFHCSA-N 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- NDXSOKGYKCGYKT-VEVYYDQMSA-N Thr-Pro-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O NDXSOKGYKCGYKT-VEVYYDQMSA-N 0.000 description 1
- ARPONUQDNWLXOZ-KKUMJFAQSA-N Tyr-Gln-Arg Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ARPONUQDNWLXOZ-KKUMJFAQSA-N 0.000 description 1
- ZMDCGGKHRKNWKD-LAEOZQHASA-N Val-Asn-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ZMDCGGKHRKNWKD-LAEOZQHASA-N 0.000 description 1
- RYQUMYBMOJYYDK-NHCYSSNCSA-N Val-Pro-Glu Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O)N RYQUMYBMOJYYDK-NHCYSSNCSA-N 0.000 description 1
- QIVPZSWBBHRNBA-JYJNAYRXSA-N Val-Pro-Phe Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O QIVPZSWBBHRNBA-JYJNAYRXSA-N 0.000 description 1
- UVHFONIHVHLDDQ-IFFSRLJSSA-N Val-Thr-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O UVHFONIHVHLDDQ-IFFSRLJSSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 108010070944 alanylhistidine Proteins 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 210000002390 cell membrane structure Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 108010016616 cysteinylglycine Proteins 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000002050 diffraction method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 1
- 229960002064 kanamycin sulfate Drugs 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 108010064235 lysylglycine Proteins 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000005476 size effect Effects 0.000 description 1
- 108010005652 splenotritin Proteins 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 108010073969 valyllysine Proteins 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P3/00—Preparation of elements or inorganic compounds except carbon dioxide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention discloses an artificially synthesized nano silver synthetic protein gene, an expressed protein and application thereof, and the artificially designed nano silver synthetic protein with certain reducibility is supported by the related technology of protein engineering according to the common characteristics of ferritin family protein sequences. The DNA sequence of the protein is shown as SEQ NO. 1, and the amino acid sequence is shown as SEQ NO. 2. The protein can efficiently synthesize nano silver, has high synthesis efficiency, and the synthesized nano silver solution is brown, and has good broad-spectrum antibacterial property and remarkable antibacterial effect.
Description
Technical Field
The invention belongs to the technical field of bioengineering, and relates to a nano silver synthetic protein, in particular to an artificially synthesized nano silver synthetic protein gene, and an expressed protein and application thereof.
Background
The nano silver is a metal simple substance with the particle size reaching the nano level, has tiny particles and large specific surface area, and has super-strong permeability. The nano silver changes the cell membrane structure by releasing anions, so that cell fluid leaks; can also react with the sulfhydryl groups in important enzymes in the cell interior to prevent the cell from dividing; it also prevents DNA replication and thus causes apoptosis. Because of its physical antibacterial ability, nano silver has broad-spectrum antibacterial property and extremely low drug resistance which are not possessed by the traditional inorganic antibacterial agents.
Currently, the mainstream nano-silver synthesis methods are classified into three categories: 1. physical methods, using mechanical grinding or laser ablation of bulk silver material to obtain nano silver powder. The product obtained by synthesizing nano silver by a physical method is easy to agglomerate, and a plurality of steps which are difficult to control exist in the synthesis process, so that the energy consumption is high and the requirement on equipment is high. 2. In the chemical method, a reducing agent, a protective agent and a dispersing agent are added into silver salt solution, and silver salt is reduced into silver simple substance under proper conditions. The process is simple, but more chemical reagents are used in the process, so that the environmental pollution is large, and the subsequent waste liquid treatment is difficult. 3. The biological method is used for preparing nano silver through biological functions inside and outside biological cells. The nano silver is prepared by utilizing certain organisms in the nature, such as extracting solutions with strong reducibility, such as methanogen or fungi and active ingredients in plants, the preparation condition is mild, any chemical reagent which is unfavorable for environmental protection is not needed, biological resources are fully utilized, and the sustainable development green environment-friendly effect can be achieved.
Disclosure of Invention
Aiming at the defects of the prior art, the invention aims to provide an artificially synthesized nano silver synthetic protein gene, and an expressed protein and application thereof. The protein expressed by the artificial synthetic protein gene lock belongs to the ferritin family protein and can be used for efficiently synthesizing nano silver.
The invention is realized by the following technical scheme:
an artificially synthesized nano silver synthetic protein gene, the DNA sequence of which is shown in SEQ NO. 1.
The invention also provides the nano silver synthetic protein obtained by coding the artificially synthesized nano silver synthetic protein gene.
Further, the nano silver synthetic protein is a protein of the following (1) or (2):
(1) A protein having an amino acid sequence as shown in SEQ NO. 2;
(2) The protein with nano silver synthesis capability is formed by substituting, deleting and adding one or more amino acid residues in the amino acid sequence shown as SEQ NO. 2.
The invention also provides a recombinant vector, which consists of an empty vector and a target gene inserted into the empty vector, wherein the target gene is a gene with a DNA sequence shown as SEQ NO. 1.
Further, the empty vector is pET-28a.
Furthermore, the invention also provides a recombinant bacterium, wherein the recombinant bacterium has a gene with a DNA sequence shown as SEQ NO. 1.
The invention further improves the scheme as follows:
the application of the nano silver synthetic protein in synthesizing nano silver.
Further, when synthesizing nano silver, the concentration of the silver nitrate substrate is 5-50mM, the synthesis reaction temperature is 20-70 ℃, the pH is 11, and the reaction time is 12-24h.
Compared with the prior art, the invention has the beneficial effects that:
1. according to the common characteristics of methanogen iron sulfur protein family, by means of the related technical support of protein engineering and combining the related parameters of reducibility, water solubility and the like of various amino acids, various possible conditions of combining with silver ions are simulated through molecular pairing, and the amino acid sequence shown as SEQ NO. 2 is designed and screened. The protein can synthesize nano silver under alkaline condition without other reagents. The synthesis conditions are simple, the equipment requirements are low, and the method is environment-friendly.
2. When the artificially designed iron-sulfur protein family protein is used for efficiently synthesizing nano silver, the pH range is 10-11, the temperature range is 20-70 ℃ and the synthesis time is 12-24h. The obtained nano silver solution is brown, has stable property and has antibacterial effect after being stored for one month at room temperature.
3. The nano silver synthesized by the protein has good antibacterial effect on staphylococcus aureus, escherichia coli, bacillus subtilis and yeast, and has wide application prospect and industrial value.
Drawings
FIG. 1 is an electrophoresis diagram of an artificially designed protein of the iron-sulfur protein family Mcy SDS-PAGE;
FIG. 2 is a full-wavelength scan of a 5-fold dilution of a synthetic nanosilver solution;
FIG. 3 shows the results of a plate bacteriostasis experiment using the protein synthesized nanosilver of the present invention, wherein a is yeast, b is Staphylococcus aureus, and c is Escherichia coli.
Detailed Description
The invention will be further illustrated with reference to specific examples.
Materials, reagents and the like used in the following examples were obtained commercially unless otherwise specified.
EXAMPLE 1 preparation of artificially designed genes for the iron-sulfur protein family proteins
Summarizing the preference and structural commonality of the methanogen ferritin family protein amino acid through database comparison analysis, and designing an amino acid sequence framework by means of protein engineering technology; simulating the three-dimensional structure of the amino acid sequence skeleton by using alpha fold 2; using AutoDock to simulate the interaction condition of silver ions and proteins, optimizing an amino acid skeleton, and preferentially selecting amino acids with higher activity such as aspartic acid, histidine, serine and the like as electron donors in nano silver synthesis; the high-frequency amino acid in the heat-resistant proteins such as proline, isoleucine and arginine are matched for supplementing, so that the structural strength of the protein is improved; protein solubility is also predicted taking into account protein solubility. The amino acid sequence shown as SEQ NO. 2 is obtained; and designing a DNA sequence shown as SEQ NO. 1 according to codon preference of an expression host, and artificially synthesizing the gene fragment.
Example 2 construction and verification of recombinant cloning and expression vectors.
The synthesized target gene fragment (prepared in example 1) and pET-28a (Novagen) were digested with XbaI and XhoI, respectively, and the digested PCR and large fragment of the vector were recovered by agarose electrophoresis. The target fragment after the rubber cutting recovery was ligated with the vector by adding 1. Mu.L of 10 XLigase Buffer and 1. Mu.L of Ligase overnight at 16 ℃. Coli DH 5. Alpha. Was transformed with the ligation reaction product, and then plated on a petri dish containing 100. Mu.g/mL Kana (Kana penicillin), and incubated at 37℃for 10-15 h.
A plurality of single colonies were picked from the transformation plate and plasmids were extracted using the plasmid miniprep kit of BIOMIGA. The obtained plasmid was verified by double cleavage and the obtained recombinant plasmid was sequenced. Sequencing results show that the cloned target fragment (with the nucleotide length of 432 bp) is inserted into the pET-28a vector, so that recombinant clone and an expression vector pET-28 a-Mcy 11 are obtained, the DNA sequence of the expressed protein gene is shown as SEQ NO. 1, the amino acid sequence of the expressed protein is shown as SEQ NO. 2, and the protein is named as Tp Mcy11.
EXAMPLE 3 expression and purification of recombinant nanosilver synthetic protein Tp Mcy11
Recombinant cloning and expression vector pET-28 a-Mcy 11 (prepared in example 2) are subjected to heat shock transformation to host bacteria E.coli BL21 (DE 3) (Novagen) to obtain recombinant bacteria containing recombinant plasmids. Single colony recombinant bacteria were inoculated in 5 mL Luria-Bertani broth (LB) medium containing 100. Mu.g/mL of kanapecillin, and shake cultured at 200 rpm at 37℃for 4h. The 4. 4 mL strain is inoculated into a 2000 mL shake flask containing 800 mL culture medium, cultured under shaking at 37℃and 200 rpm, when the absorbance reaches 0.4-0.6, 800. Mu.L of 0.1M IPTG is added, and induced to express 15 h at 22℃and 150 rpm. The culture broth was centrifuged at 6000 rpm for 10 min at 4℃with a high-speed refrigerated centrifuge, and the cells were collected. The cells were recovered by washing with 50 mL ultra pure water and centrifuging at 6000 rpm for 10 min at 4℃followed by 20: 20 mL Binging Buffer resuspension (0.5M NaCl,20mM Tris-HCl,5mM Imidazole,pH 7.4), disrupting the bacterial cells with an ultrasonic disrupter in an ice-water bath and centrifuging at 10000 rpm for 50 min at 4℃to obtain a crude extract of recombinant nano silver synthetic protein Tp Mcy11.
The crude extract was purified using a Ni-NTA affinity column (see His-Band kit, novagen). The purity of the purified protein was identified and the molecular weight was determined by SDS-PAGE, and the results are shown in FIG. 1,1 for 200 mM imidazole eluted purified Mcy protein. The molecular weight is about 16 kDa, which is close to the theoretical value.
Example 4 Synthesis of nanosilver Using recombinant nanosilver Synthesis protein Tp Mcy11
The purified protein solution obtained in example 3 was dialyzed to remove imidazole and NaCl, concentrated to 15mg/ml by ultrafiltration, and concentrated according to the silver nitrate concentration (mM): the final protein concentration (μg/ml) =1:2 ratio was prepared by preparing 30ml of the reaction solution, adjusting the pH to 11 with sodium hydroxide, and shaking the solution for 20 hours at 30 ℃ with a shaking table at 150rpm to obtain a dark brown nano silver solution, the full wavelength scan of which is shown in fig. 2. The nano silver solution generally shows an absorption peak at a full wavelength of 410mm-440mm, and the higher the nano silver concentration, the higher the absorption peak in a certain concentration range. In the case of nanoparticles, the absorption wavelength of the nanomaterial moves in the short wave direction due to quantum size effect as the particle size decreases; the smaller the particle diameter of the synthesized nano silver particles, the more the peak is shifted in the 400mm direction. The full-wavelength scanning result of the nano silver particles synthesized by the protein shows that the obtained nano silver particles have uniform particle diameter and smaller particle diameter, and the particle diameter distribution is about 20mm through dynamic light diffraction analysis.
Example 5 experiment of Nano silver antibacterial Ring
Preparation of pathogen plates: 2ml of an overnight culture medium of pathogenic bacteria (Staphylococcus aureus ATCC6538, escherichia coli ATCC25922, torulopsis globosa) was added to 100ml of LB medium containing 2% nutrient agar, and the mixture was poured into a dish. 6. Mu.l of 50. Mu.g/ml ampicillin or kanamycin sulfate, the supernatant of the nano silver synthesis solution without adding protein, the protein solution with sodium chloride removed by dialysis, and the nano silver solution synthesized by Tp Mcy11 were adsorbed on each filter paper sheet. Culturing in an incubator at 37 ℃ for 24 hours. The situation of the inhibition zone is found: the supernatant of the nano silver synthetic solution without protein and the protein solution have no antibacterial effect, and the supernatant of the nano silver synthetic solution with protein has obvious antibacterial circle, which proves that the protein can synthesize nano silver, and the nano silver has a certain antibacterial effect on fungi (candida globosa), gram positive bacteria (staphylococcus aureus ATCC 6538) and gram negative bacteria (escherichia coli ATCC 25922).
Sequence listing
<110> Huaiyin institute of technology
<120> an artificially synthesized nano silver synthetic protein gene, and expressed protein and application thereof
<130> 2021
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 432
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 1
gaagtgaacc agcagaccga agatattgat cgcgatattc gcgtgaaata tcagcgcatt 60
aaaaccggct ttattattat tccgatgcgc aaagaacagg aagtgatgaa aattctgagc 120
acccagttta ccgtgccgga atatcatggc accgtgaccg aagcgctgga agtgaacgaa 180
aaactgattg atcgcgcggg caaagaaagc cagcaggtga ccccggatct ggatgatacc 240
gtgccgttta tggcggaaga aatgaaaggc ctgccgggcc tgcgcgtgat taacgaaatt 300
gatgatattg atctgaacga tgcgattgaa tgcggcaaag gccgcctggg caacatgatt 360
gaaaaactgg aagcgattca gaccgatgaa gcgcatgtgc ataaactgga actgtttatt 420
cgcgaaaccc tg 432
<210> 2
<211> 144
<212> PRT
<213> Artificial sequence (Artificial sequence)
<400> 2
Glu Val Asn Gln Gln Thr Glu Asp Ile Asp Arg Asp Ile Arg Val Lys
1 5 10 15
Tyr Gln Arg Ile Lys Thr Gly Phe Ile Ile Ile Pro Met Arg Lys Glu
20 25 30
Gln Glu Val Met Lys Ile Leu Ser Thr Gln Phe Thr Val Pro Glu Tyr
35 40 45
His Gly Thr Val Thr Glu Ala Leu Glu Val Asn Glu Lys Leu Ile Asp
50 55 60
Arg Ala Gly Lys Glu Ser Gln Gln Val Thr Pro Asp Leu Asp Asp Thr
65 70 75 80
Val Pro Phe Met Ala Glu Glu Met Lys Gly Leu Pro Gly Leu Arg Val
85 90 95
Ile Asn Glu Ile Asp Asp Ile Asp Leu Asn Asp Ala Ile Glu Cys Gly
100 105 110
Lys Gly Arg Leu Gly Asn Met Ile Glu Lys Leu Glu Ala Ile Gln Thr
115 120 125
Asp Glu Ala His Val His Lys Leu Glu Leu Phe Ile Arg Glu Thr Leu
130 135 140
Claims (6)
1. An artificially synthesized nano silver synthetic protein is characterized by being obtained by encoding a gene shown in SEQ NO. 1.
2. A recombinant vector comprising an empty vector and a target gene inserted into the empty vector, wherein the target gene is the gene according to claim 1.
3. A recombinant vector according to claim 2, wherein: the empty vector is pET-28a.
4. A recombinant bacterium comprising the gene of claim 1.
5. Use of the nano-silver synthesis protein according to claim 1 for synthesizing nano-silver.
6. The use of the nano-silver synthetic protein according to claim 5, wherein: when synthesizing nano silver, the concentration of the silver nitrate substrate is 5-50mM, the synthesis reaction temperature is 20-70 ℃, the pH is 11, and the reaction time is 12-24h.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111665678.8A CN114381456B (en) | 2021-12-31 | 2021-12-31 | Artificially synthesized nano silver synthetic protein gene, expressed protein and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111665678.8A CN114381456B (en) | 2021-12-31 | 2021-12-31 | Artificially synthesized nano silver synthetic protein gene, expressed protein and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114381456A CN114381456A (en) | 2022-04-22 |
CN114381456B true CN114381456B (en) | 2023-09-22 |
Family
ID=81200463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111665678.8A Active CN114381456B (en) | 2021-12-31 | 2021-12-31 | Artificially synthesized nano silver synthetic protein gene, expressed protein and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114381456B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002022799A2 (en) * | 2000-09-14 | 2002-03-21 | Forschungszentrum Jülich GmbH | Method for the microbial production of metabolic products, polynucleotides from coryneform bacteria and use thereof |
CN109456993A (en) * | 2018-11-28 | 2019-03-12 | 上海安民生物技术有限公司 | The albumin expression vectors of the promoter containing CAG |
CN110804089A (en) * | 2019-10-18 | 2020-02-18 | 淮阴工学院 | Nano-silver synthetic protein derived from spherical lysine bacillus and application thereof |
CN113341042A (en) * | 2021-06-18 | 2021-09-03 | 辽宁中医药大学 | Screening and application of biomarker related to AD cell model constructed by Abeta induction |
CN113444721A (en) * | 2021-07-09 | 2021-09-28 | 淮阴工学院 | Artificial modified gene, SNA15protein and method for efficiently synthesizing nano-silver by using SNA15protein |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150003617A (en) * | 2013-07-01 | 2015-01-09 | 서강대학교산학협력단 | Bioprocessing Device |
-
2021
- 2021-12-31 CN CN202111665678.8A patent/CN114381456B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002022799A2 (en) * | 2000-09-14 | 2002-03-21 | Forschungszentrum Jülich GmbH | Method for the microbial production of metabolic products, polynucleotides from coryneform bacteria and use thereof |
CN109456993A (en) * | 2018-11-28 | 2019-03-12 | 上海安民生物技术有限公司 | The albumin expression vectors of the promoter containing CAG |
CN110804089A (en) * | 2019-10-18 | 2020-02-18 | 淮阴工学院 | Nano-silver synthetic protein derived from spherical lysine bacillus and application thereof |
CN113341042A (en) * | 2021-06-18 | 2021-09-03 | 辽宁中医药大学 | Screening and application of biomarker related to AD cell model constructed by Abeta induction |
CN113444721A (en) * | 2021-07-09 | 2021-09-28 | 淮阴工学院 | Artificial modified gene, SNA15protein and method for efficiently synthesizing nano-silver by using SNA15protein |
Non-Patent Citations (2)
Title |
---|
Differential gene regulation in the Ag nanoparticle and Ag(+)-induced silver stress response in Escherichia coli:a full transcriptomic profile;Jonathan S McQuillan等;Nanotoxicology;全文 * |
不同特性纳米银氧化应激效应及机制研究;王君君;中国优秀硕士学位论文全文数据库 工程科技I辑;全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN114381456A (en) | 2022-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106755209B (en) | Method for preparing beta-nicotinamide mononucleotide by enzyme method | |
CN108467857B (en) | PET hydrolase mutant and application thereof | |
CN109825484B (en) | Zearalenone hydrolase ZHD101 mutant and method for hydrolyzing zearalenone by using mutant | |
KR102141353B1 (en) | Method for producing a recombinant protein of interest | |
Zhu et al. | A simple and effective strategy for solving the problem of inclusion bodies in recombinant protein technology: His-tag deletions enhance soluble expression | |
CN108864303B (en) | Antifungal fusion protein and related biological material and application thereof | |
CN112501151A (en) | Nitrile hydratase mutant and application thereof | |
KR101774354B1 (en) | Z domain-calsequestrin fusion protein for antibody isolation and purification and method of isolating and purifying antibody using the same | |
CN109182310B (en) | Application of radiation-resistant Gobi deinococcus keratin gene | |
CN114381456B (en) | Artificially synthesized nano silver synthetic protein gene, expressed protein and application thereof | |
WO2021103295A1 (en) | Recombinant chitin deacetylase, and preparation method therefor and use thereof | |
WO2014096245A1 (en) | Method for producing a recombinant protein of interest | |
CN112824527A (en) | Artificially designed lysyl endonuclease, coding sequence and fermentation method | |
CN112725315B (en) | Application of chitosanase and mutant thereof in preparation of chitosan oligosaccharide | |
CN114369589A (en) | Preparation and application of chitinase mutant | |
CN113444721B (en) | Artificial modified gene, SNA15protein and method for efficiently synthesizing nano silver by using same | |
CN108660127B (en) | Artificially designed penicillin G acylation zymogen and coding sequence and application thereof | |
CN113061590B (en) | Algae toxin degrading enzyme, composite material and application | |
CN112501150B (en) | Chitin deacetylase, coding gene thereof, recombinant vector, recombinant strain, leavening agent, enzyme preparation and application of chitin deacetylase, recombinant strain, leavening agent and enzyme preparation | |
CN111019927B (en) | Recombinant plasmid for expressing TEV protein, recombinant engineering bacterium and method for preparing and purifying TEV protein | |
CN108753758B (en) | Hyperthermophilic lipase LipL and related biological material and application thereof | |
CN110923223A (en) | Novel nitrilase and application thereof | |
WO2020063267A1 (en) | Phytase mutant | |
CN110904076B (en) | Potassium chloride-resistant xylosidase mutant K317D and application thereof | |
CN108841804B (en) | Hyperthermophilic lipase LipH and related biological material and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240112 Address after: 518000 909, Building 49, No. 3, Queshan Yunfeng Road, Taoyuan Community, Dalang Street, Longhua District, Shenzhen, Guangdong Patentee after: Shenzhen Morning Intellectual Property Operations Co.,Ltd. Address before: 223400 8th floor, Anton building, No. 10, Hai'an Road, Lianshui County, Huai'an City, Jiangsu Province Patentee before: HUAIYIN INSTITUTE OF TECHNOLOGY |
|
TR01 | Transfer of patent right |